Illumina’s General Counsel Accepts Advisory Role As Search Begins for Successor

Charles Dadswell has stepped down as Illumina's general counsel and secretary but will advise CEO Jacob Thaysen and the Board of Directors through early 2025.

Scott Davies has been named acting general counsel and secretary while the San Diego DNA sequencing company (NASDAQ: ILMN ) conducts a search for Dadswell's successor.

Dadswell joined the company as general counsel in 2013, following a distinguished career providing legal counsel to the biotechnology sector. He left the general counsel role on Thursday and will serve as adviser until March 31, 2025, the company said in a news release.

Most recently, Dadswell oversaw the company's challenge in the European Court of Justice of the European Commission's jurisdiction over Illumina's acquisition of GRAIL .

"Throughout his tenure, Chuck has been a valuable adviser to Illumina's leadership team and its Board of Directors. He is a respected industry leader whose expertise and advice helped Illumina reach the industry leadership role it holds today," Thaysen said.

He added, "I speak for everyone at Illumina when I say how appreciative we are for his many contributions to our organization."

Dadswell said Illumina has "significantly accelerated science and medicine to the benefit of millions of people around the world."

"I've watched and been a part of Illumina growing from a start-up to one of the most important and innovative companies in the world, and I'm proud to have been a part of that journey," he said.

Davies joined Illumina in 2009. He most recently served as vice president for legal, chief corporate counsel and assistant secretary.